Paper41394151
Part 1 - imidazolines and the changing face of nasal decongestants.
Stinson RJ and 1 other. Front Pharmacol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Part 1 - imidazolines and the changing face of nasal decongestants. Papers, record 41394151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41394151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32466864 | Using pictures to convey health information: A systematic review and meta-analysis of the effects on patient and consumer health behaviors and outcomes. | Patient Educ Couns | 2020 | https://conductscience.org/library/papers/32466864 | PubMed |
| 2 | 34355529 | The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/34355529 | PubMed |
| 3 | 40580050 | Revisiting Rhinitis Medicamentosa: Examining the Evidence on Topical Nasal Decongestants. | J Pharm Pract | 2026 | https://conductscience.org/library/papers/40580050 | PubMed |
| 4 | 38188313 | Naphazoline intoxication with transient QT prolongation and acute myocardial injury. | J Cardiol Cases | 2024 | https://conductscience.org/library/papers/38188313 | PubMed |
| 5 | 39535583 | European Pharmaceutical Industry Medical Information: A Role to Play in the Provision of Medicine-Related Information to Patients. | Pharmaceut Med | 2024 | https://conductscience.org/library/papers/39535583 | PubMed |
| 6 | 30215971 | Epistaxis: Outpatient Management. | Am Fam Physician | 2018 | https://conductscience.org/library/papers/30215971 | PubMed |
| 7 | 17388561 | Theoretical assessment of naphazoline redoxchemistry and photochemistry. | J Phys Chem B | 2007 | https://conductscience.org/library/papers/17388561 | PubMed |
| 8 | 6104975 | Pharmacology of centrally acting hypotensive drugs. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6104975 | PubMed |
| 9 | 3513687 | Efficacy and safety of topical oxymetazoline in treating allergic and environmental conjunctivitis. | Ann Ophthalmol | 1986 | https://conductscience.org/library/papers/3513687 | PubMed |
| 10 | 241844 | Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines. | J Pharmacol Exp Ther | 1975 | https://conductscience.org/library/papers/241844 | PubMed |
| 11 | 20016692 | Treating rhinitis in the older population: special considerations. | Allergy Asthma Clin Immunol | 2009 | https://conductscience.org/library/papers/20016692 | PubMed |
| 12 | 2671220 | Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. | J Laryngol Otol | 1989 | https://conductscience.org/library/papers/2671220 | PubMed |
| 13 | 6154514 | Rhinitis medicamentosa. | Can Med Assoc J | 1980 | https://conductscience.org/library/papers/6154514 | PubMed |
| 14 | 6289955 | Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/6289955 | PubMed |
| 15 | 35010673 | The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/35010673 | PubMed |
| 16 | 31858187 | Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey. | Eur J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31858187 | PubMed |
| 17 | 21313640 | The Use and Misuse of Drugs in Symptomatic Treatment of the Allergic Nose. | Postgrad Med J | 1959 | https://conductscience.org/library/papers/21313640 | PubMed |
| 18 | 26065640 | Evaluating the Effect of Sinex® (0.05% Oxymetazoline) Nasal Spray on Reduction of Nasal Congestion Using Computational Fluid Dynamics. | J Biomech Eng | 2015 | https://conductscience.org/library/papers/26065640 | PubMed |
| 19 | 11063925 | Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain. | Neuropsychopharmacology | 2000 | https://conductscience.org/library/papers/11063925 | PubMed |
| 20 | 39119149 | A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependence. | INNOSC Theranostics Pharmacol Sci | 2024 | https://conductscience.org/library/papers/39119149 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42331734 | Co(II), Cu(II), and Ni(II) Coordination Complexes: Synthesis, Characterization, Experimental, and Computational Study on Potential Antiplasmodial Activity. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42331734 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41394151
GET https://conductscience.org/api/papers/v1/41394151/references?page=2